140 Comparison of overall survival (OS) between pembrolizumab monotherapy and combination therapy in advanced non-small cell lung cancer (aNSCLC) patients in NHS Tayside

Lung Cancer 2026

View at publisher

Authors: Ting Feng Ho, Ee Qing Thee, Hannah Lord

DOI: 10.1016/j.lungcan.2026.109089

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment